Search

Your search keyword '"Hiraki S"' showing total 380 results

Search Constraints

Start Over You searched for: Author "Hiraki S" Remove constraint Author: "Hiraki S"
380 results on '"Hiraki S"'

Search Results

2. A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease

11. Flexibility of production ordering systems.

12. 428. Inframesocolic superior mesenteric artery first approach as an introductory procedure of radical antegrade modular pancreatosplenectomy for distal pancreatic cancer

13. 12. The prognostic value of the lymph node ratio for resected pancreatic ductal carcinoma

14. OBSERVATION OF MOLTEN STEEL FLOW IN SUBMERGED ENTRY NOZZLE

20. Randomized phase III trial of docetaxel and cisplatin combination chemotherapy versus mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer: OLCSG 0007

24. Randomized phase III trial of docetaxel and cisplatin combination chemotherapy versus mitomycin, vindesine and cisplatin combination chemotherapy with concurrent thoracic radiation therapy for locally advanced non-small cell lung cancer: Preliminary report

27. The impact of drug administration sequence in a triplet chemotherapy comprising cisplatin, docetaxel and gemcitabine in patients with advanced non-small cell lung cancer: A phase II study of the Okayama Lung Cancer Study Group (OLCSG)

28. Cisplatin plus irinotecan (PI) alternating with a three-drug combination of doxorubicin, cyclophosphamide and etoposide (ACE) in patients with extensive-stage small-cell lung cancer (ED-SCLC): A phase II study of Okayama Lung Cancer Study Group (OLCSG)

35. Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group

39. Fractionated administration of cisplatin (CDDP) and irinotecan (CPT-11) in patients with stage IIIB and IV non-small-cell lung cancer (NSCLC): A phase II study

40. Phase II study of cisplatin (CDDP) and 5-fluorouracil (5-FU) with concurrent hyperfractionated thoracic radiotherapy (HFTRT) for locally advanced non-small-cell lung cancer (LA-NSCLC): A preliminary report from the Okayama Lung Cancer Study Group

41. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group

48. Genetic counseling practice analysis.

49. Perceptions of familial risk in those seeking a genetic risk assessment for Alzheimer's disease.

50. Phase I/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer.

Catalog

Books, media, physical & digital resources